NFE2L2 and obesity due to melanocortin 4 receptor deficiency: In summary, based on the present findings and prior literature, further studies are warranted to examine the role of NRF2 in dexamethasone treatment using models of obesity or diabetes with gain or loss of NRF2 signaling.